Rajeev K. Tyagi
Dr. Tyagi has been leading a group at CSIR-Institute of Microbial Technology, Chandigarh, India. He obtained his Ph.D. in 2011 at the Biomedical Parasitology Unit, Institute Pasteur, Paris, where he developed a long-lasting, stable and straightforward laboratory animal model (humanized mouse model). Dr. Tyagi’s post-doctoral work was carried out at the University of South Florida, Augusta University and Vanderbilt University Medical Center (VUMC), USA, where he used the humanized mouse model as a tool to study the infectious disease P. falciparum and inflammatory diseases (P. gingivalis, colitis). His current research group is working on the development of human-liver chimeric mice for huHep transplantation, the antimalarial and anti-inflammatory potential of oleuropein has been explored in the asexual blood stage infection of P. falciparum and in-vitro models of inflammation (LPS- stimulated human THP-1 macrophages), and. on formulation and characterization of nanoscale drug carriers to deliver methotrexate (MTX) and aceclofenac in the treatment of rheumatoid arthritis, breast cancer and other inflammatory diseases.